FDA Inspection 931561 — INTERVASCULAR, SAS

INTERVASCULAR, SAS — FEI 3002707083

The FDA completed an inspection of INTERVASCULAR, SAS on Jun 18, 2015 in La Ciotat Cedex. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jun 18, 2015
Fiscal Year
2015
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
La Ciotat Cedex (France)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.